Mon-Fri 9:00-18:00 CET+39 095 7211344info@vitasanlabs.com

Family · Pharmaceutical analytical standards

Benazepril

An ACE inhibitor that the body converts into the active metabolite benazeprilat, used for high blood pressure and heart failure; patented in 1981, it has been in use since 1990. This family brings together the active ingredient, pharmacopoeial impurities, metabolites, labelled standards, nitrosamines and other impurities.

Did you know?It is also used in veterinary medicine: in dogs with heart failure and in cats and dogs with chronic kidney disease.

BenazeprilGo to the active ingredient →
BenazeprilActive ingredientBenazeprilCat. No. P-B026-001CAS 86541-75-5
ent-BenazeprilPharmacopoeial impurityent-BenazeprilCat. No. P-B026-003CAS 131064-75-0

EDQM standards 3

The official European Pharmacopoeia standards for this family.

Need a molecule you cannot find?

Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.